CG Oncology CGON Investment Proceeds
Investment Proceeds at other companies
Other financials
Where this comes from
Reported directly by CG Oncology in its filing.
Tagged under the XBRL concept us-gaap:ProceedsFromSaleMaturityAndCollectionsOfInvestments.
The official record: CG Oncology’s 10-Q, filed May 8, 2026, on SEC EDGAR. View the filing →
Ask your AI about CG Oncology's investment proceeds.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI

Claude
Questions, answered.
- What is CG Oncology's investment proceeds?
- CG Oncology (CGON) reported investment proceeds of $252.85M in Q1 2026.
- How has CG Oncology's investment proceeds changed year-over-year?
- CG Oncology's investment proceeds increased by 26.3% year-over-year, from $200.14M to $252.85M.
- What does investment proceeds mean?
- Cash received from sales, maturities, and redemptions of investment securities across all categories.